The investigators propose to conduct a comparative pilot cognitive and psychiatric profiles of 10 patients Facio-Scapulo-Humeral Dystrophy (= FHSD) type 1 and 10 patients with type 2 FSHD study. For this, the investigators relied on observational components: FSHD2 patients appear more often present with psychiatric comorbidities and seem to have lower cognitive performance compared to FSHD1 patients. This was confirmed by a preliminary study on a small sample population of patients. It seems to exist mainly executive dysfunction associated with attention disorders in patients FSHD2. Moreover, their performance in IQ tests would be low in relation to their socio-educational and compared with patients FSHD1 level.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Montgomery and Asberg Depression Rating Scale
Timeframe: One time at the inclusion
Hamilton Depression Rating Scale
Timeframe: One time at the inclusion
Hamilton Anxiety Rating Scale
Timeframe: One time at the inclusion
Quick inventory of depressive symptomatology Self report
Timeframe: One time at the inclusion
Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form
Timeframe: One time at the inclusion
Mini Mental Status Evaluation
Timeframe: One time at the inclusion
Wechsler Adult Intelligence Scale
Timeframe: One time at the inclusion